Information Library
Results for: Oncology - Product Development & Commercialization - Central Laboratories
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
The Molecular Biomarker Revolution in Non-Small Cell Lung Cancer
White Paper — June 23, 2011
In this new white paper Quintiles’ experts Christopher Ung, Jason Hill, Carrie Lee and Harish Dave review some of the most promising molecular pathways and targeted approaches for NSCLC, the critical role of diagnostics, and strategies to detect and address the emergence of resistance. -
Quintiles and Population Genetics Technologies Partner
Press Release — May 16, 2011 – Quintiles, and Population Genetics Technologies Ltd. (PGT), announced a commercial collaboration to bring genomic testing into mainstream drug development in order to produce safer, more effective medicines.
-
Dr. Frank Massam
Hear from the Experts — May 13, 2011
Dr. Frank Massam discusses the significance of Quintiles' partnership with Population Genetics Technologies Ltd. -
Podcast: Clinical Development of Cancer Drugs in China
Hear from the Experts — October 18, 2010
Hear exclusive interviews with Quintiles's experts, Christopher Ung, Patty James and Harish Dave on their recent participation at the 13th Annual Chinese Society of Clinical Oncology -
Biomarker Trends in Breast Cancer Research
White Paper — February 24, 2010
Dr. Hill discusses the implications and questions that will drive future R&D efforts to develop targeted breast cancer therapies. -
QUINTILES ADVANCES CANCER TREATMENT THROUGH NEW GENETIC TESTS
Press Release — May 26, 2009 – Targeted Molecular Diagnostics (TMD), a Quintiles Central Laboratory, announces the availability of two new laboratory tests used to develop more effective cancer treatments.
Page 1 of 1 (6 results)
